A handful of drug companies with big vaccine portfolios are especially well-positioned to capitalize on the effects of climate change, according to a Morgan Stanley investors’ note.

The big picture: Climate change will be a business opportunity for some pharmaceutical companies. That’s nothing cynical — infectious diseases will spread faster and farther as the climate warms, and we treat infectious diseases with drugs.

The bottom line: Vaccine development is hard and expensive, so companies that are already in that business will have an upper hand, Morgan Stanley’s analysts wrote.

  • Sanofi and GlaxoSmithKline are at the top of the heap, the bank says, given their existing pipelines and manufacturing capacity.
  • Takeda and Merck both have vaccines in the works for dengue fever, one of the diseases that climate change is likely to exacerbate.
  • Janssen and Pfizer are both active in the vaccines market, but would need to establish new research programs to take on tropical diseases, per Morgan Stanley.

Go deeper: Climate change could be big business for pharma

Go deeper

Mayors plan multifront attack on census shutdown

Illustration: Sarah Grillo/Axios

A growing number of mayors are banding together to fight what they consider to be an inaccurate and abruptly curtailed 2020 census, using an arsenal of legal, legislative and congressional efforts.

Why it matters: The outcome may determine whether President Trump or Joe Biden controls the redistricting process, which governs everything from congressional representation and redistricting to funding for schools and Head Start.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: Many U.S. deaths were avoidable — The pandemic is getting worse again.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.
3 hours ago - Technology

Facebook Oversight Board begins hearing appeals

Illustration: Aïda Amer/Axios

The Facebook Oversight Board announced Thursday that some Facebook and Instagram users can now submit appeals to the Oversight Board for an independent review of their own content removals.

Why it matters: The board, a first-of-its-kind internet governance body, will begin hearing cases from users ahead of the U.S. election.